BACKGROUND: A colostomy is known to impact negatively on a patient's quality of life (QOL). Concerns include incontinence, rectal discharge, gas, difficulties in returning to work, decreased sexual activity, and travel and leisure challenges. Reports have described QOL outcomes in cancer patients with colostomies and inflammatory bowel syndrome with colostomies, but little has been written regarding a comparison of cancer and non-cancer populations. The purpose of this study was to describe QOL issues of colostomy patients and compare these issues in cancer and non-cancer participants. MATERIALS AND METHODS: A QOL-ostomy questionnaire was mailed to 2455 California members of the United Ostomy Association. RESULTS: Of the 1457 respondents (59%), 599 had a colostomy. Most were results from cancer (517/599), with colorectal cancer being the most common diagnosis. The most common benign diagnoses were inflammatory bowel disease and diverticulitis. Demographics were similar, except for more females in the non-cancer group (76%), and increased length of time with colostomy from the cancer group (mean 135.9 versus 106.4 months, P = 0.03). Common QOL problems included sexual problems, gas, constipation, travel difficulties, and dissatisfaction with appearance. Overall, cancer patients had less difficulty adjusting to their colostomies. CONCLUSIONS: Results confirmed the negative impact of a colostomy on QOL. While patients with cancer had a better overall QOL than those with benign processes, concerns were common to all colostomy patients. These results provide health care practitioners with information useful in discussing QOL concerns during pre-operation treatment decisions and post operative teaching and follow-up care.
BACKGROUND: A colostomy is known to impact negatively on a patient's quality of life (QOL). Concerns include incontinence, rectal discharge, gas, difficulties in returning to work, decreased sexual activity, and travel and leisure challenges. Reports have described QOL outcomes in cancerpatients with colostomies and inflammatory bowel syndrome with colostomies, but little has been written regarding a comparison of cancer and non-cancer populations. The purpose of this study was to describe QOL issues of colostomy patients and compare these issues in cancer and non-cancerparticipants. MATERIALS AND METHODS: A QOL-ostomy questionnaire was mailed to 2455 California members of the United Ostomy Association. RESULTS: Of the 1457 respondents (59%), 599 had a colostomy. Most were results from cancer (517/599), with colorectal cancer being the most common diagnosis. The most common benign diagnoses were inflammatory bowel disease and diverticulitis. Demographics were similar, except for more females in the non-cancer group (76%), and increased length of time with colostomy from the cancer group (mean 135.9 versus 106.4 months, P = 0.03). Common QOL problems included sexual problems, gas, constipation, travel difficulties, and dissatisfaction with appearance. Overall, cancerpatients had less difficulty adjusting to their colostomies. CONCLUSIONS: Results confirmed the negative impact of a colostomy on QOL. While patients with cancer had a better overall QOL than those with benign processes, concerns were common to all colostomy patients. These results provide health care practitioners with information useful in discussing QOL concerns during pre-operation treatment decisions and post operative teaching and follow-up care.
Authors: Karen E Steinhauser; Robert M Arnold; Maren K Olsen; Jennifer Lindquist; Judith Hays; Laura L Wood; Allison M Burton; James A Tulsky Journal: J Pain Symptom Manage Date: 2011-01-28 Impact factor: 3.612
Authors: M Jane Mohler; Stephen Joel Coons; Mark C Hornbrook; Lisa J Herrinton; Christopher S Wendel; Marcia Grant; Robert S Krouse Journal: Curr Med Res Opin Date: 2008-06-09 Impact factor: 2.580
Authors: Virginia Sun; Christopher S Wendel; Wendy Demark-Wahnefried; Marcia Grant; Carmit K McMullen; Joanna E Bulkley; Lisa J Herrinton; Mark C Hornbrook; Robert S Krouse Journal: Nutr Cancer Date: 2018-12-20 Impact factor: 2.900
Authors: Virginia Sun; Marcia Grant; Christopher S Wendel; Carmit K McMullen; Joanna E Bulkley; Andrea Altschuler; Michelle Ramirez; Carol M Baldwin; Lisa J Herrinton; Mark C Hornbrook; Robert S Krouse Journal: Ann Surg Oncol Date: 2015-07-10 Impact factor: 5.344
Authors: Mark C Hornbrook; Christopher S Wendel; Stephen Joel Coons; Marcia Grant; Lisa J Herrinton; M Jane Mohler; Carol M Baldwin; Carmit K McMullen; Sylvan B Green; Andrea Altschuler; Susan M Rawl; Robert S Krouse Journal: Med Care Date: 2011-03 Impact factor: 2.983
Authors: Virginia Sun; Marcia Grant; Carmit K McMullen; Andrea Altschuler; M Jane Mohler; Mark C Hornbrook; Lisa J Herrinton; Carol M Baldwin; Robert S Krouse Journal: J Wound Ostomy Continence Nurs Date: 2013 Jan-Feb Impact factor: 1.741
Authors: Liyan Liu; Lisa J Herrinton; Mark C Hornbrook; Christopher S Wendel; Marcia Grant; Robert S Krouse Journal: Dis Colon Rectum Date: 2010-02 Impact factor: 4.585
Authors: Carol M Baldwin; Marcia Grant; Christopher Wendel; Mark C Hornbrook; Lisa J Herrinton; Carmit McMullen; Robert S Krouse Journal: J Clin Sleep Med Date: 2009-08-15 Impact factor: 4.062
Authors: Andrea Altschuler; Michelle Ramirez; Marcia Grant; Christopher Wendel; Mark C Hornbrook; Lisa Herrinton; Robert S Krouse Journal: J Wound Ostomy Continence Nurs Date: 2009 May-Jun Impact factor: 1.741